Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angioedema Biomarker Research Study

NCT06210698 is registered in ClinicalTrials.gov with Foundation For Rare Disease Research as lead sponsor.

NCT NCT06210698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angioedema Biomarker Research Study
Lead sponsor
Foundation For Rare Disease Research
Phase
Observational
Overall status
Recruiting
Start date
January 15, 2024
Completion date
August 1, 2027
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ace inhibitor-induced angioedema, angioedema, angioedemas, hereditary, c1 inhibitor deficiency, indolent systemic mastocytosis, mastocytosis, systemic mastocytoses, urticaria